The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese Encephalitis
Open accessAbstract
Yellow fever (YF) 17D vaccine virus, having a 60-year history of safe and effective use, is an ideal vector to deliver heterologous genes from other medically important flaviviruses. A chimeric YF/Japanese encephalitis (JE) virus (ChimeriVax-JE virus) was constructed by insertion of the premembrane and envelope (prME) genes of an attenuated human vaccine strain (SA14-14-2) of Japanese encephalitis (JE) virus between core and nonstructural (NS) genes of a YF 17D infectious clone. The virus grew to high titers in cell cultures and was not neurovirulent for 3- to 4-week-old mice at doses </=6 log10 plaque forming units (pfu) inoculated by the intracerebral (IC) route. In contrast, commercial YF 17D vaccine was highly neurovirulent for weanling mice by the same route. Mice inoculated subcutaneously with one dose of >/=10(3) pfu of ChimeriVax-JE virus were solidly protected against intraperitoneal challenge with a virulent JE virus. Genetic stability of the chimera was assessed by sequential passages in cell cultures or in mouse brain. All attenuating residues and the avirulent phenotype were preserved after 18 passages in cell cultures or 6 passages in mouse brains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence
Chumakov, K. M., Norwood, L. P., Parker, M. L., Dragunsky, E. M., Ran, Y. X., & Levenbook, I. S. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.966-970.1992 · Cited by 72
Cited by
Molecular biology of flaviviruses
Lindenbach, B. D., & Rice, C. M. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)59002-9 · Cited by 853
Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R., & Pulendran, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051720 · Cited by 552
Guy, B., Guirakhoo, F., Barban, V., Higgs, S., Monath, T. P., & Lang, J. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.09.098 · Cited by 291
Self-citationJapanese encephalitis: The virus and vaccines
Yun, S.-I., & Lee, Y.-M. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26902 · Cited by 288
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
Barrett, P. N., Mundt, W., Kistner, O., & Howard, M. K. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.19 · Cited by 281
Metadata
- Authors
- Guirakhoo, F., Zhang, Z.-X., Chambers, T. J., Delagrave, S., Arroyo, J., Barrett, A. D. T., & Monath, T. P.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 1999-05
- Volume
- 257
- Issue
- 2
- Pages
- 363-372
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W2004688624
- Cited by
- 171
- References
- 1
- FWCI
- 11.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese Encephalitis. https://app.cochat.ai/papers/10.1006/viro.1999.9695
- The paper
- Guirakhoo, F., Zhang, Z.-X., Chambers, T. J., Delagrave, S., Arroyo, J., Barrett, A. D. T., & Monath, T. P. (1999). Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese Encephalitis. Virology. https://doi.org/10.1006/viro.1999.9695
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.